{"id":190,"date":"2023-07-12T13:20:38","date_gmt":"2023-07-12T13:20:38","guid":{"rendered":"https:\/\/epsilogen.com\/?post_type=team&#038;p=190"},"modified":"2023-07-12T13:20:38","modified_gmt":"2023-07-12T13:20:38","slug":"emma-johnson","status":"publish","type":"team","link":"https:\/\/epsilogen.com\/team\/emma-johnson\/","title":{"rendered":"Emma Johnson"},"content":{"rendered":"<p>Emma is a Senior Investment Manager in the British Patient Capital Direct Investments team, where she focuses on opportunities in the life sciences. Emma joined the BPC team in September 2021 at the launch of Future Fund: Breakthrough and has led investments into companies spanning novel therapeutic modalities and technologies driving efficiencies in the life sciences sector. Previously, Emma spent three years investing in a broad array of life sciences companies for the Greater Manchester and Cheshire Life Sciences Fund managed by Catapult Ventures. Emma also joined Fund Her North as a founding member with the goal of increasing access to finance for female entrepreneurs in the North of England and has a background in Neuroscience.<\/p>\n","protected":false},"featured_media":183,"template":"","acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.3 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Emma Johnson - Epsilogen<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/epsilogen.com\/team\/emma-johnson\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Emma Johnson - Epsilogen\" \/>\n<meta property=\"og:description\" content=\"Emma is a Senior Investment Manager in the British Patient Capital Direct Investments team, where she focuses on opportunities in the life sciences. Emma joined the BPC team in September 2021 at the launch of Future Fund: Breakthrough and has led investments into companies spanning novel therapeutic modalities and technologies driving efficiencies in the life [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/epsilogen.com\/team\/emma-johnson\/\" \/>\n<meta property=\"og:site_name\" content=\"Epsilogen\" \/>\n<meta property=\"og:image\" content=\"https:\/\/epsilogen.com\/wp-content\/uploads\/2023\/07\/emma-johnson.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1153\" \/>\n\t<meta property=\"og:image:height\" content=\"1153\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/epsilogen.com\/team\/emma-johnson\/\",\"url\":\"https:\/\/epsilogen.com\/team\/emma-johnson\/\",\"name\":\"Emma Johnson - Epsilogen\",\"isPartOf\":{\"@id\":\"https:\/\/epsilogen.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/epsilogen.com\/team\/emma-johnson\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/epsilogen.com\/team\/emma-johnson\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/epsilogen.com\/wp-content\/uploads\/2023\/07\/emma-johnson.jpg\",\"datePublished\":\"2023-07-12T13:20:38+00:00\",\"dateModified\":\"2023-07-12T13:20:38+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/epsilogen.com\/team\/emma-johnson\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/epsilogen.com\/team\/emma-johnson\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/epsilogen.com\/team\/emma-johnson\/#primaryimage\",\"url\":\"https:\/\/epsilogen.com\/wp-content\/uploads\/2023\/07\/emma-johnson.jpg\",\"contentUrl\":\"https:\/\/epsilogen.com\/wp-content\/uploads\/2023\/07\/emma-johnson.jpg\",\"width\":1153,\"height\":1153},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/epsilogen.com\/team\/emma-johnson\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/epsilogen.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Emma Johnson\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/epsilogen.com\/#website\",\"url\":\"https:\/\/epsilogen.com\/\",\"name\":\"Epsilogen\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/epsilogen.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/epsilogen.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/epsilogen.com\/#organization\",\"name\":\"Epsilogen\",\"url\":\"https:\/\/epsilogen.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/epsilogen.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/epsilogen.com\/wp-content\/uploads\/2023\/07\/logo.svg\",\"contentUrl\":\"https:\/\/epsilogen.com\/wp-content\/uploads\/2023\/07\/logo.svg\",\"width\":267,\"height\":64,\"caption\":\"Epsilogen\"},\"image\":{\"@id\":\"https:\/\/epsilogen.com\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Emma Johnson - Epsilogen","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/epsilogen.com\/team\/emma-johnson\/","og_locale":"en_US","og_type":"article","og_title":"Emma Johnson - Epsilogen","og_description":"Emma is a Senior Investment Manager in the British Patient Capital Direct Investments team, where she focuses on opportunities in the life sciences. Emma joined the BPC team in September 2021 at the launch of Future Fund: Breakthrough and has led investments into companies spanning novel therapeutic modalities and technologies driving efficiencies in the life [&hellip;]","og_url":"https:\/\/epsilogen.com\/team\/emma-johnson\/","og_site_name":"Epsilogen","og_image":[{"width":1153,"height":1153,"url":"https:\/\/epsilogen.com\/wp-content\/uploads\/2023\/07\/emma-johnson.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/epsilogen.com\/team\/emma-johnson\/","url":"https:\/\/epsilogen.com\/team\/emma-johnson\/","name":"Emma Johnson - Epsilogen","isPartOf":{"@id":"https:\/\/epsilogen.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/epsilogen.com\/team\/emma-johnson\/#primaryimage"},"image":{"@id":"https:\/\/epsilogen.com\/team\/emma-johnson\/#primaryimage"},"thumbnailUrl":"https:\/\/epsilogen.com\/wp-content\/uploads\/2023\/07\/emma-johnson.jpg","datePublished":"2023-07-12T13:20:38+00:00","dateModified":"2023-07-12T13:20:38+00:00","breadcrumb":{"@id":"https:\/\/epsilogen.com\/team\/emma-johnson\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/epsilogen.com\/team\/emma-johnson\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/epsilogen.com\/team\/emma-johnson\/#primaryimage","url":"https:\/\/epsilogen.com\/wp-content\/uploads\/2023\/07\/emma-johnson.jpg","contentUrl":"https:\/\/epsilogen.com\/wp-content\/uploads\/2023\/07\/emma-johnson.jpg","width":1153,"height":1153},{"@type":"BreadcrumbList","@id":"https:\/\/epsilogen.com\/team\/emma-johnson\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/epsilogen.com\/"},{"@type":"ListItem","position":2,"name":"Emma Johnson"}]},{"@type":"WebSite","@id":"https:\/\/epsilogen.com\/#website","url":"https:\/\/epsilogen.com\/","name":"Epsilogen","description":"","publisher":{"@id":"https:\/\/epsilogen.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/epsilogen.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/epsilogen.com\/#organization","name":"Epsilogen","url":"https:\/\/epsilogen.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/epsilogen.com\/#\/schema\/logo\/image\/","url":"https:\/\/epsilogen.com\/wp-content\/uploads\/2023\/07\/logo.svg","contentUrl":"https:\/\/epsilogen.com\/wp-content\/uploads\/2023\/07\/logo.svg","width":267,"height":64,"caption":"Epsilogen"},"image":{"@id":"https:\/\/epsilogen.com\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/epsilogen.com\/wp-json\/wp\/v2\/team\/190"}],"collection":[{"href":"https:\/\/epsilogen.com\/wp-json\/wp\/v2\/team"}],"about":[{"href":"https:\/\/epsilogen.com\/wp-json\/wp\/v2\/types\/team"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/epsilogen.com\/wp-json\/wp\/v2\/media\/183"}],"wp:attachment":[{"href":"https:\/\/epsilogen.com\/wp-json\/wp\/v2\/media?parent=190"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}